Inhibition of Multiple Myeloma Using 5-Aza-2ʹ-Deoxycytidine and Bortezomib-Loaded Self-Assembling Nanoparticles
Feifei Che, Jiao Chen, Jingying Dai, Xingchao Liu Organ Transplantation Center, Sichuan Academy of Medical Science and Sichuan People’s Hospital, Chengdu, Sichuan Province, People’s Republic of ChinaCorrespondence: Xingchao LiuOrgan Transplantation Center, Sichuan Academy of Medi...
Main Authors: | Che F, Chen J, Dai J, Liu X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/inhibition-of-multiple-myeloma-using-5-aza-2-deoxycytidine-and-bortezo-peer-reviewed-article-CMAR |
Similar Items
-
5-Aza-2′-Deoxycytidine Alters the Methylation Profile of Bortezomib-Resistant U266 Multiple Myeloma Cells and Affects Their Proliferative Potential
by: Karolina Łuczkowska, et al.
Published: (2023-11-01) -
Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma
by: T A Mitina, et al.
Published: (2010-07-01) -
Effects of 5-aza-2´-deoxycytidine on biological parameters of Achroia grisella F. (Lepidoptera: Pyralidae)
by: Sak Olga
Published: (2018-01-01) -
The Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Genome-Wide Hypomethylation in Rice
by: Shuo Liu, et al.
Published: (2022-07-01) -
A feline case of multiple myeloma treated with bortezomib
by: Hiroyuki Tani, et al.
Published: (2022-11-01)